Search Count: 74
 |
Crystal Structure Of Sars-Cov-2 Mpro S10A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S10C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: DMS, EDO, V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: DMS, EDO, V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S113A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S113C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro L115A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro L115M In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S147A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro S147N In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-12-10
Ligands: V2M
 |
Crystal Structure Of Human Shiftless (Sfl) Containing Phosphorylation Sites Ser249, Thr250, Thr253 And Ser256
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-11-19 Classification: ANTIVIRAL PROTEIN Ligands: ZN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-11-19
Ligands: ZN
 |
Crystal Structure Of Macrocycle Mediated Complex Of Fkbp12 And Mapre1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.77 Å Release Date: 2025-03-26 Classification: ISOMERASE Ligands: A1AZI |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-03-26
Ligands: A1AZI
 |
Fkbp1A (Fkbp12) Co-Crystal Structure With Macrocycle Molecular Glue
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2025-03-26 Classification: IMMUNOSUPPRESSANT Ligands: A1AZI |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-03-26
Ligands: A1AZI
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166A With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-03-19
Ligands: GOL, V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-03-19
Ligands: GOL, V2M
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant L50F E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: DMS, V2M, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-03-19
Ligands: DMS, V2M, CL
 |
Human Oc43 Main Protease (1-303) In Complex With Potent Inhibitor
Organism: Human coronavirus oc43
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2024-10-16 Classification: VIRAL PROTEIN Ligands: A1AUY |
Organism: Human coronavirus oc43
Method: X-RAY DIFFRACTION
Release Date: 2024-10-16
Ligands: A1AUY
 |
Co-Structure Of Sars-Cov-2 (Covid-19 With Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2024-10-16 Classification: VIRAL PROTEIN Ligands: A1AUX |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-10-16
Ligands: A1AUX
 |
Co-Structure Of Main Protease Of Sars-Cov-2 (Covid-19) With Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2024-10-16 Classification: HYDROLASE Ligands: A1AU4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-10-16
Ligands: A1AU4
 |
Crystal Structure Of Trim21 Pryspry (D355A) In Complex With Acepromazine.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-10-09 Classification: LIGASE Ligands: PMZ, FMT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-10-09
Ligands: PMZ, FMT
 |
Crystal Structure Of Trim21 Pryspry (D355A) In Complex With (S)-Hydroxyl-Acepromazine.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2024-10-09 Classification: LIGASE Ligands: A1D5Y |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-10-09
Ligands: A1D5Y
 |
Crystal Structure Of Trim21 Pryspry (D355A) In Complex With (R)-Hydroxyl-Acepromazine.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2024-10-09 Classification: LIGASE Ligands: A1D5Z |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-10-09
Ligands: A1D5Z